134 related articles for article (PubMed ID: 37850401)
1. Utility of palliative prognostic index and neutrophil-to-lymphocyte ratio in predicting prognosis of end-stage squamous cell carcinoma of head and neck.
Higashino M; Sugimoto K; Onishi S; Okabe K; Yasuda C; Tadokoro H; Kawata R
Head Neck; 2024 Jan; 46(1):23-28. PubMed ID: 37850401
[TBL] [Abstract][Full Text] [Related]
2. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
Wu F; Wu LL; Zhu LX
Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
[No Abstract] [Full Text] [Related]
3. Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
Zhou J; Wei S; Guo X; Huang Y; Zhang Y; Hong Y; Chen X; Lu M; Zheng F; Zheng C
BMC Cancer; 2023 Dec; 23(1):1247. PubMed ID: 38110870
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
[TBL] [Abstract][Full Text] [Related]
5. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis.
Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P
Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the accuracy of clinical prediction of survival and palliative prognostic index for patients with head and neck squamous cell carcinoma in the end-of-life setting.
Kishino T; Monden N; Akisada N; Hayashi Y; Nakamura M; Hashimoto K; Miyashita T; Mori T; Hoshikawa H
Auris Nasus Larynx; 2022 Feb; 49(1):133-140. PubMed ID: 34226098
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study.
Yanni A; Buset T; Bouland C; Loeb I; Lechien JR; Rodriguez A; Journe F; Saussez S; Dequanter D
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4103-4111. PubMed ID: 35099595
[TBL] [Abstract][Full Text] [Related]
8. High fibrinogen-albumin ratio index (FARI) predicts poor survival in head and neck squamous cell carcinoma patients treated with surgical resection.
Wang S; Feng Y; Xie Y; Zhao X; Ma J; Liu X; Hu C; Hou T
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4541-4548. PubMed ID: 35462579
[TBL] [Abstract][Full Text] [Related]
9. The Utility of Glasgow Prognostic Score and Palliative Prognostic Index in Patients With Head and Neck Squamous Cell Carcinoma Under Palliative Care.
Kishino T; Mori T; Miyashita T; Ouchi Y; Samukawa Y; Fukumura T; Takahashi S; Monden N; Akisada N; Hayashi Y; Nakamura M; Hoshikawa H
Ear Nose Throat J; 2023 Jun; 102(6):379-384. PubMed ID: 33765857
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck.
Ferrandino RM; Roof S; Garneau J; Haidar Y; Bates SE; Park YA; Bauml JM; Genden EM; Miles B; Sigel K
Head Neck; 2020 Oct; 42(10):2830-2840. PubMed ID: 32592262
[TBL] [Abstract][Full Text] [Related]
11. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
Takenaka Y; Oya R; Kitamiura T; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
Head Neck; 2018 Mar; 40(3):647-655. PubMed ID: 29076207
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic score based on systemic inflammatory biomarkers for patients with oral squamous cell carcinoma.
Zhuang Z; Li Y; Hong Y; Chen L; Qian J; Lin J; Chen Q; Qiu Y; Lin L; Shi B; Pan L; Zheng X; Wang J; Liu F; He B; Chen F
Oral Dis; 2022 Apr; 28(3):631-638. PubMed ID: 33426698
[TBL] [Abstract][Full Text] [Related]
14. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Yang L; Huang Y; Zhou L; Dai Y; Hu G
Head Neck; 2019 May; 41(5):1525-1535. PubMed ID: 30597654
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
Valero C; Pardo L; López M; García J; Camacho M; Quer M; León X
Head Neck; 2017 Feb; 39(2):219-226. PubMed ID: 27534525
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-lymphocyte ratio in head and neck cancer.
Haddad CR; Guo L; Clarke S; Guminski A; Back M; Eade T
J Med Imaging Radiat Oncol; 2015 Aug; 59(4):514-519. PubMed ID: 25908427
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta-analysis.
Takenaka Y; Oya R; Takemoto N; Inohara H
Head Neck; 2022 May; 44(5):1237-1245. PubMed ID: 35146824
[TBL] [Abstract][Full Text] [Related]
18. Blood Markers Predicting Clinically Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma.
Gaudioso P; Borsetto D; Polesel J; Tirelli G; Emanuelli E; Menegaldo A; Molteni G; Nicolai P; Tomasoni M; Montenegro C; Piazza C; Bossi P; Ciorba A; Canzi P; Giacomarra V; Giudici F; Fussey J; Boscolo-Rizzo P
ORL J Otorhinolaryngol Relat Spec; 2024; 86(1):32-40. PubMed ID: 37972574
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of neutrophil-to-lymphocyte ratio to laryngeal squamous cell carcinoma: a meta-analysis.
Zhao Y; Qin J; Qiu Z; Guo J; Chang W
Braz J Otorhinolaryngol; 2022; 88(5):717-724. PubMed ID: 33272836
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.
Charles KA; Harris BD; Haddad CR; Clarke SJ; Guminski A; Stevens M; Dodds T; Gill AJ; Back M; Veivers D; Eade T
BMC Cancer; 2016 Feb; 16():124. PubMed ID: 26892430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
